Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours (2021)

First Author: Mowday A
Attributed to:  SBRC NOTTINGHAM: Sustainable Routes to Platform Chemicals funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41417-021-00296-7

PubMed Identifier: 33558701

Publication URI: http://europepmc.org/abstract/MED/33558701

Type: Journal Article/Review

Parent Publication: Cancer Gene Therapy

Issue: 2

ISSN: 0929-1903